ArticleCancer2013

The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.

Vikas Sehdev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.